The Oncology Institute, Inc.
General ticker "TOI" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $243.7M (TTM average)
The Oncology Institute, Inc. follows the US Stock Market performance with the rate: 37.6%.
Estimated limits based on current volatility of 3.7%: low 4.45$, high 4.79$
Factors to consider:
- Total employees count: 750 as of 2022
- Top business risk factors: Pandemic risks, Internal control weaknesses, Rapid growth and organizational change, Market competition, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.28$, 4.63$]
- 2026-12-31 to 2027-12-31 estimated range: [0.74$, 2.93$]
Financial Metrics affecting the TOI estimates:
- Positive: with PPE of -6.9 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.73 <= 0.78
- Negative: Shareholder equity ratio, % of -9.55 <= 19.24
- Negative: Industry operating cash flow per share per price (median), % of 5.14 <= 5.46
- Negative: Industry operating profit margin (median), % of 0.04 <= 2.88
- Negative: -0.16 < Industry inventory ratio change (median), % of 0
Short-term TOI quotes
Long-term TOI plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $393.41MM | $502.73MM |
| Operating Expenses | $453.53MM | $538.81MM |
| Operating Income | $-60.12MM | $-36.08MM |
| Non-Operating Income | $-4.54MM | $-24.65MM |
| Interest Expense | $7.50MM | $11.28MM |
| Income(Loss) | $-64.66MM | $-60.74MM |
| Taxes | $0.00MM | $-0.13MM |
| Net Income(Loss)* | $-64.66MM | $-60.61MM |
| Stockholders Equity | $3.59MM | $-15.72MM |
| Assets | $172.72MM | $164.66MM |
| Operating Cash Flow | $-26.54MM | $-24.59MM |
| Capital expenditure | $3.79MM | $3.20MM |
| Investing Cash Flow | $46.21MM | $-3.07MM |
| Financing Cash Flow | $-3.49MM | $11.56MM |
| Earnings Per Share** | $-0.86 | $-0.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.